WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
Chinese scientists invent ultrathin optical crystal for nextKentucky AD Barnhart: No comment on suit by former swimmers alleging sexual misconduct by exMike Tyson sends warning shot to Jake Paul ahead of their July 20 fight, as 57TV series spotlights young love for older womanTourism boom promotes revitalization of intangible cultural heritage2023 in review: A fruitful year for China's manned space programSpaceX launches 23 more Starlink internet satellites into spaceChina launches construction of biomedical platform for disease researchChina develops robot for cultural relics protectionMedical brain
3.2798s , 6497.7578125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Culture Circle news portal